Sanfu Chemical Announces Board Approval of 2nd Quarter 2026 Consolidated Financial Report

1. Date reported to or resolved by the Board of Directors: 115/08/12 2. Date approved by the Audit Committee: 115/08/12 3. Reporting period for financial statements or self-compiled annual financial information: Start date to end date (XXX/XX/XX~XXX/XX/XX): 115/01/01~115/06/30 4. Cumulative operating revenue from January 1 to current period (in thousands of NTD): 2,371,319 5. Cumulative gross profit (loss) from January 1 to current period (in thousands of NTD): 548,132 6. Cumulative operating income (loss) from January 1 to current period (in thousands of NTD): 255,529 7. Cumulative pre-tax net profit (loss) from January 1 to current period (in thousands of NTD): 287,993 8. Cumulative net profit (loss) for the period from January 1 to current period (in thousands of NTD): 210,134 9. Cumulative net profit (loss) attributable to owners of the parent from January 1 to current period (in thousands of NTD): 234,551 10. Cumulative basic earnings per share (loss) from January 1 to current period (NTD): 2.33 11. Total assets at the end of the period (in thousands of NTD): 10,586,304 12. Total liabilities at the end of the period (in thousands of NTD): 3,556,204 13. Equity attributable to owners of the parent at the end of the period (in thousands of NTD): 6,815,387 14. Other matters to be disclosed: None